Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.
about
The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferationOsteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in miceEssential role of PKC-zeta in normal and angiotensin II-accelerated neointimal growth after vascular injuryDevelopment of progressive aortic vasculopathy in a rat model of agingOsteopontin is required for the early onset of high fat diet-induced insulin resistance in micePPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosisDifferential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosisPD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism.Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes.Antigen-specific induction of osteopontin contributes to the chronification of allergic contact dermatitisOsteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome.Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.A Dominant-Negative PPARgamma Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle CellsAngiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin APeroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysmMonocyte chemoattractant protein-1 deficiency protects against visceral fat-induced atherosclerosis.Molecular determinants of the cardiometabolic phenotype.Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in miceUnilateral renal artery stenosis causes a chronic vascular inflammatory response in ApoE-/- mice.T-bet-dependent expression of osteopontin contributes to T cell polarization.Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progressionReactive oxygen species regulate osteopontin expression in a murine model of postischemic neovascularization.Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragmentEfficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression.Genes and abdominal aortic aneurysm.Resistin derived from diabetic perivascular adipose tissue up-regulates vascular expression of osteopontin via the AP-1 signalling pathwayCombination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm.Neutralization of osteopontin attenuates neutrophil migration in sepsis-induced acute lung injury.Complex pathologies of angiotensin II-induced abdominal aortic aneurysmsProlonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm.Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm.Matricellular proteins in cardiac adaptation and disease.Primary sclerosing cholangitis--the arteriosclerosis of the bile duct?Performance comparison of ultrasound-based methods to assess aortic diameter and stiffness in normal and aneurysmal mice
P2860
Q24677863-AA9C35DC-EADF-4E64-8A37-B62E275C5E2AQ27327172-E16A7EBB-D3CB-41CF-BD2D-098FA0EA284CQ28579623-7F3DBE93-BCB6-461D-9896-A80DEA5162DBQ28583371-D6230A53-09EC-43D6-B6FF-7C9F5D357816Q28748481-B5C334DD-D4EE-4EBE-8124-063DA9495C97Q30482025-233E7BC4-03C0-4C2C-8691-E1571DED9118Q30483132-63C4DF13-0893-491B-AF20-4163234578C8Q30502726-A30F0DE0-0DB6-4663-9011-846B158B0F2EQ31115399-90F1E7C9-D9E3-46B4-86D4-9AE34BFDB6FBQ31124912-08937AC7-2DAE-4AE3-B49F-5A9B33CA866CQ33556319-9CBF8102-B8B0-4F35-B7F5-C714D12A0409Q33569709-3712F889-6B3F-4479-B6FF-2E0CA2F44282Q33605449-72A17DC2-082C-43C9-8B82-BC703CE33586Q33724886-3BA1849D-7142-4F20-87E2-967110B93961Q33738515-AAA08020-C334-4E6B-887B-9ACEBBC2BF43Q33766277-61EAA398-F7F4-407F-8F10-BD0C201959EDQ33818137-FDD2C75B-8C63-4C68-8AF8-D8920B4FD60DQ33820531-3996BBA3-963B-4DB1-9092-A5CE7737239AQ33867271-9E3E393E-748D-4726-8839-04070890D3D2Q33921392-2D9CE834-2903-4ED8-879E-2697A2FC8A13Q33976385-033C8BF6-AE84-4A3C-8288-2A0CE04650F2Q33985855-185A0029-419E-49DB-9486-D1E11A52E94EQ34048495-ABDF3536-AC67-4298-99AA-B9BD6392C8FAQ34144801-1D1F3BC8-438D-4D3F-B518-5882F81BAEE0Q34150874-37225549-D267-4E0D-8204-6FF8E8EF6136Q34227711-EAC6A468-7451-4692-AB63-1FF498685AECQ34245106-34039912-AB83-4E9F-8DCB-EEE07285E118Q34506416-4630C433-01EC-4221-99E5-B5C967CEBFA0Q34532189-091EEDFB-CA55-43BA-83C0-5803FD4D483AQ34683905-ED45F895-FBE1-43D4-AE6A-FAB6A4C91D4CQ34851451-4FA1E65A-061E-4296-9B50-79227FAECFACQ34965343-CA560F56-C648-4CC3-A662-43BB15F92005Q35126452-30A27787-5363-434A-861F-DE0D5F7B8344Q35132945-9910C88B-9944-4EDA-9471-FD0102DDC0EAQ35148843-15B765F6-ADF3-4F2A-897F-D43B39A0C2B5Q35167994-C6B46FB9-8530-430E-A5D0-5198004F4958Q35233864-D5564196-9C7E-437E-9425-3F3CFECCE67CQ35542423-C59DE902-97F2-4339-8D7A-CADBFBC6BA96Q35632527-1D3B236C-8B4C-4B14-A868-DADDDE346934Q35645966-1A76E3BA-59F7-4C2C-847C-CA86953F520E
P2860
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Angiotensin II-accelerated ath ...... in osteopontin-deficient mice.
@ast
Angiotensin II-accelerated ath ...... in osteopontin-deficient mice.
@en
type
label
Angiotensin II-accelerated ath ...... in osteopontin-deficient mice.
@ast
Angiotensin II-accelerated ath ...... in osteopontin-deficient mice.
@en
prefLabel
Angiotensin II-accelerated ath ...... in osteopontin-deficient mice.
@ast
Angiotensin II-accelerated ath ...... in osteopontin-deficient mice.
@en
P2093
P2860
P356
P1476
Angiotensin II-accelerated ath ...... in osteopontin-deficient mice.
@en
P2093
Alan R Collins
Dennis Bruemmer
Florian Blaschke
Kristof Graf
Mary Territo
Michael C Fishbein
Ronald E Law
Sarah Arias-Magallona
P2860
P304
P356
10.1172/JCI200318141
P407
P577
2003-11-01T00:00:00Z